Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Update: With New Data, Don’t Count J&J Out Yet

Sep 22 2021

• By Scrip Team

COVID gears (shutterstock) — • Source: Shutterstock

Related Content

Coronavirus Update: Regeneron's REGEN-COV Authorized For Prevention

Jul 30 2021

BioNTech Extends Global Reach, Ambition With Kite’s Neoantigen T-Cell Receptor Assets

Jul 19 2021

Coronavirus Update: Another Vaccine Disappointment For GSK

Feb 02 2021

Coronavirus Update: Pfizer/BioNTech Commit 500m Doses For US Donations

Jun 15 2021

US 500m Dose Donation Takes Shine From China Vaccine Diplomacy

Jun 11 2021

Moderna Reports ‘Robust’ Response From COVID-19 Booster Shots

Aug 05 2021

Coronavirus Update: Sanofi And GSK’s Vaccine Suffers Setback

Dec 11 2020

Veklury Still Keeping Gilead Above Water Amid Pandemic, Patent Expiries

Apr 29 2021

Coronavirus Pipeline: GSK And Clover Add To Collaborations

Feb 24 2020

Coronavirus Update: Gilead's Veklury Gets Full FDA Approval, Roche Partners With Atea

Oct 23 2020

Related Companies

Johnson & Johnson

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Gilead Sciences, Inc.

Regeneron Pharmaceuticals, Inc.

Clover Biopharmaceuticals, Inc.

Dynavax Technologies Corporation

GSK plc

Sanofi

Additional Topics

Coronavirus COVID-19 Vaccines Research & Development Infectious Diseases

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window